Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non‐high‐grade serous ovarian carcinomas.

Autor: Kramer, CJH, Lanjouw, L, Ruano, D, ter Elst, A, Santandrea, G, Solleveld‐Westerink, N, Werner, N, van der Hout, AH, de Kroon, CD, van Wezel, T, Berger, LPV, Jalving, M, Wesseling, J, Smit, VTHBM, de Bock, GH, van Asperen, CJ, Mourits, MJE, Vreeswijk, MPG, Bart, J, Bosse, T

Publikováno v: Journal of Pathology; Feb2024, Vol. 262 Issue 2, p137-146, 10p

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.

Autor: Jamieson A; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, Canada., Vermij L; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kramer CJH; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Jobsen JJ; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Jürgemlienk-Schulz I; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Lutgens L; MAASTRO Clinic, Maastricht, the Netherlands., Mens JW; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Haverkort MAD; Radiotherapiegroep Arnhem, Arnhem, the Netherlands., Slot A; Radiotherapeutic Institute Friesland, Leeuwarden, the Netherlands., Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Carlson J; Department of Pathology, University of Southern California, Los Angeles., Howitt BE; Department of Pathology, Stanford University School of Medicine, Palo Alto., Ip PPC; Department of Pathology, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Lax SF; Department of Pathology, Hospital Graz II, Medical University of Graz, Graz, and Johannes Kepler University, Linz, Austria., McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom., Singh N; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., McAlpine JN; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, Canada., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 01; Vol. 29 (23), pp. 4949-4957.

The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks.

Autor: van Wijk LM; Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Kramer CJH; Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Vermeulen S; Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Ter Haar NT; Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., de Jonge MM; Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., de Kroon CD; Department of Gynecology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Gaarenstroom KN; Department of Gynecology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Vrieling H; Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2021 Jun 15; Vol. 13 (12). Date of Electronic Publication: 2021 Jun 15.

The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.

Autor: Kramer CJH; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Vangangelt KMH; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., van Pelt GW; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Dekker TJA; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Mesker WE; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. w.e.mesker@lumc.nl.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Jan; Vol. 173 (1), pp. 55-64. Date of Electronic Publication: 2018 Oct 09.